Objective: The sympathetic nervous system enhances cardiac muscle function by activating ␤ adrenergic receptors (␤ARs). Recent studies suggest that chronic ␤AR stimulation is detrimental, however, and that it may play a role in the clinical deterioration of patients with congestive heart failure. To examine the impact of chronic ␤1AR and ␤2AR subtype stimulation individually, we studied the cardiovascular effects of catecholamine infusions in ␤AR subtype knockout mice (␤1KO, ␤2KO).
T he ␤1 adrenergic receptors (␤1ARs) and ␤2ARs are closely related receptor subtypes that mediate the primary cardiovascular effects of catecholamines in the mammalian heart. Both receptors are G protein coupled and possess seven transmembrane helixes. Both receptors have been shown to enhance heart contractility (1, 2) as well as relaxation (1). In addition, they share many common agonists and antagonists.
Despite these similarities, ␤1AR and ␤2ARs differ in many ways. For instance, their gene loci are entirely different. The ␤1AR gene is located on chromosome 10 whereas the gene for the ␤2AR resides on chromosome 5. The receptor subtypes differ in size: The ␤2AR is 477 amino acids in length whereas the ␤1AR is 413 amino acids (3, 4) . Also, recent investigations suggest that ␤1ARs and ␤2ARs have unique signaling properties. ␤2ARs in cultured rat and mouse ventricular myocytes couple to both stimulatory (G s ) and inhibitory (G i ) G proteins whereas ␤1ARs couple only to G s . Furthermore, in rat neonatal cardiac myocytes, ␤2AR activation has been shown to deliver an antiapoptotic signal to cardiac myocytes through a G i -dependent coupling to phosphatidylinositol 3'-kinase and Akt (protein kinase B). In contrast, ␤1AR activation in adult rat ventricular myocytes has been shown to increase apoptosis via a cyclic adenosine monophosphatedependent mechanism (5, 6) .
Previous studies using transgenic mice suggest that when ␤1ARs and ␤2ARs are expressed at levels many times greater than normal, their effects are also different. For example, five-fold transgenic overexpression of ␤1ARs in the murine heart causes cardiomyopathy (7) , whereas overexpression of ␤2ARs, even at levels as high as 60-fold above normal, improves cardiac contractile force without any cardiomyopathic consequences (8) .
Although these data suggest dissimilar roles for cardiac ␤1ARs and ␤2ARs, the degree to which they reveal differences between the two receptor subtypes during chronic activation is unclear. The effects of receptor overexpression may, in fact, differ from those of continuous stimulation. For example, the extent to which signaling elements are activated may be strongly influenced by variations in receptor expression levels. ␤2ARs, for instance, appear to operate within microdomains (9) . Signal transduction elements within these domains may be finite, and it is conceivable that at some level overexpression exceeds the capacity of these microdomains and leads to atypical receptor signaling.
Our approach to the study of chronic ␤AR subtype activation has been to use knockout mice. Using this approach we have investigated the effects of chronically stimulating individual ␤AR subtypes expressed at physiologic levels. Our pilot studies (mortality rate and exercise capacity studies using small numbers of animals) suggested that mice lacking ␤1ARs (␤1KO and ␤1␤2KO) might be resistant to isoproterenol-induced cardiac injury. They also suggested that ␤2KO mice might be more susceptible to the detrimental effects of isoproterenol infusion than wild-type animals. Based on these preliminary findings, we focused our investigation on ␤2KO mice. We examined the cardiovascular effects of chronic ␤1AR activation in the absence of ␤2AR stimulation in vivo.
METHODS
Mice. These experiments were reviewed and approved by our institution's Subcommittee on Animal Studies and were in accordance with the provisions of the Animal Welfare Act, the Public Health Service Guide for the Care and Use of Laboratory Animals. The generation of ␤1KO, ␤2KO, and ␤1␤2 adrenergic receptor double knockout (␤1␤2dKO) mice has been previously described (10 -12) . All mice used in these experiments were male mice between 25 and 35 g. The ␤2KO mice and their strain-specific wild-type control animals were on congenic FVB/N backgrounds.
We infused isoproterenol or saline into ␤2KO and strain-specific wild-type control animals for 2 wks. The study groups were carefully matched in terms of age, weight, gender, and living environment. We studied 30 Ϯ 3 g male mice between 12 and 14 wks of age. Within genotypes, littermates were divided evenly and randomly assigned to isoproterenol or saline infusion, rather than assigning entire litters to one treatment or the other.
Reagents. (Ϫ)-Isoproterenol bitartrate (120 g·g Ϫ1 ·day Ϫ1 ; Sigma Chemical, St. Louis, MO) was infused subcutaneously into each study animal via miniosmotic pumps (Alza Corporation, Palo Alto, CA). Control animals received infusions of sterile 0.9% sodium chloride (Abbott Laboratories, North Chicago, IL).
Surgery and Anesthesia. Miniosmotic pumps were placed subcutaneously in each mouse under general anesthesia. We used 3% isoflurane anesthesia for induction of anesthesia; 1.5% isoflurane was used for maintenance. Each animal was allowed to breathe spontaneously throughout the procedure. A small subcutaneous pouch was created on each animal's flank using blunt-end forceps. The osmotic pumps were inserted, and the skin was closed using two 7.5 ϫ 1.75 mm skin staples (Michel).
Mortality Investigation. The mortality investigation included mice that resided in individual cages for the duration of the study after undergoing infusion pump insertions. These animals were not included in any physiology experiments. Two separate mortality investigations were conducted. The data were pooled for analysis. In total, 36 isoproterenol-treated ␤2KO, 33 isoproterenol-treated wild-type, 22 saline-treated ␤2KO, and 30 saline-treated wild-type animals were studied.
Exercise Capacity. Several mice were challenged individually with a graded treadmill exercise protocol on a Simplex II rodent treadmill (Columbus Instruments, Columbus, OH). The animals were studied 1 day before and 17 days after osmotic pump insertion (3 days after the pump contents had been completely injected). Treadmill activity was initiated after each mouse had equilibrated in the exercise chamber for 10 mins. Stepwise increases in treadmill speed (2.5 m/min) and inclination (2°) were made every 3 mins until each mouse stopped running from exhaustion. Exercise capacity was calculated as the total distance run by the animal during the exercise protocol.
Left Ventricle Change in Pressure Over Time (dp/dt). Each animal studied was anesthetized using isoflurane as previously described. The animal's neck was shaved and prepped in sterile fashion, and a midline neck skin incision was made. The right common carotid artery was isolated using a microscope. A suture was tied around the vessel approximately 0.25 cm below the skull base. Approximately 0.75 cm proximal to this point, blood flow was disrupted using a vascular clamp. This provided a site for insertion of a Mikro-tip catheter transducer (Millar Instruments, Houston Texas). The contralateral carotid artery was allowed to remain patent, maintaining adequate cerebral blood flow on the right side of the brain by perfusion through the circle of Willis. Proximal to the point of carotid artery ligation, a small arterotomy incision was made using a curved 25-gauge needle. The Mikro-tip catheter was introduced into the artery and advanced under waveform guidance into the left ventricle. A pressure waveform was generated using an amplifier (Gould Instrument Systems, Valley View, OH), a Transducer Control Unit TC-510 (Millar Instruments), a Dell Optiplex GX300 Computer (Dell Computer, Austin, TX), and WinDaq Acquisition Software version 2.43 (DATAQ Instruments, Akron, OH). The ventricular pressure was measured before and after intraperitoneal injection of propranolol (30 mg/kg), which was used to block the effects of endogenous catecholamines that might have a greater impact on dp/dt in mice of one genotype relative to the other. To calculate dp/dt based on the left ventricle waveform, WinDaq Waveform Browser software (DATAQ Instruments) was used.
Right Ventricle Mean Systolic Pressure. Each animal studied was anesthetized using isoflurane as previously described. The animal's chest was shaved and prepped in sterile fashion. A 22-gauge needle was placed into the right ventricle using a transcutaneous subxiphoid approach. Using a Transpac IV Monitoring Kit (Abbott Critical Care Systems, North Chicago, IL), an SN-E8748 Interface Cable (Fogg System, Aurora, CO), a Gould 13-6615 Transducer (Gould Instrument Systems, Babylon, N Y), a PowerLab 14SP (ADInstruments, Mountain View, CA), an Apple Power-Mac G4 Computer running OS9.1 Operating System (Apple Computer, Cupertino, CA), and Chart version 3.6.3/s software (ADInstruments), the right ventricle pressure waveform was transduced and recorded for 5 secs. At a later time, the peak of each pressure waveform was identified manually and all the peak systolic pressures over the course of 5 secs were averaged to generate a right ventricle mean systolic pressure.
Noninvasive (Tail Cuff) Blood Pressure and Heart Rate. A BP 2000 Physiologic Research Instrument (Visitech Systems, Apex, NC) was used to determine systolic blood pressure at two time points before osmotic pump insertion and at nine time points after osmotic pump insertion for several animals. Before the study, each animal underwent 2 wks of blood pressure measurement training. For training, each animal underwent 20 tail cuff blood pressure measurements every other day. At each time point during the study, each animal underwent ten practice measurements followed by ten actual measurements. A mean heart rate and systolic blood pressure were determined by the BP 2000 instrument for each animal at each time point.
Electrocardiography. Each animal studied was anesthetized using isoflurane as previously described. The animal's chest was shaved and prepped in sterile fashion. Using transcutaneous needle electrodes, a PhysioTel TA10EA-F20 Transmitter (Data Sciences International, St. Paul, MN), a PhysioTel Receiver RPC-1 (Data Sciences International), a BCM100 Consolidation Matrix Device (Data Sciences International), a Powerlab 14SP (ADInstruments), an Apple PowerMac G4 Computer (Apple Computer), and Chart version 3.6.3/s software, an eight-lead electrocardiogram (ECG) was performed before and at several time points after initiation of saline or isoproterenol infusion. All ECGs were interpreted by a board eligible cardiologist.
Organ Weight to Body Weight Ratios. The mice that underwent exercise treadmill testing were anesthetized using 0.5 mg/g of body weight (about 0.5 mL) Avertin administered by injection into the peritoneum. Each animal was weighed and then killed using cervical dislocation. A clam-shell bilateral thoracotomy incision followed by a midline abdominal incision was immediately performed, and the heart, lungs, liver, spleen, and kidneys were removed. Each organ was rinsed in saline, blotted dry, and immediately weighed. Organ weight to body weight ratios were then calculated for each animal using these values.
Electron Microscopy and Analyses. Tissue was fixed for Ն8 hrs at room temperature in 1.5% glutaraldehyde (cacodylate buffer, pH 7.4); sucrose was added to bring the milliosmolarity to 300. The tissue was stored at 4°C and dehydrated in ethanol, transferred to propylene oxide, and embedded in Epon 12 resin. Polymerized blocks were sectioned at 0.5-1 m, and the sections were stained with toluidine blue for examination by light microscopy. Selected areas were sectioned at 0.05 m, enhanced with uranyl acetate and lead citrate, and examined with a Philips 201 electron microscope. A quantitative analysis of myocyte injury was performed by a pathologist subspecializing in cardiac pathology. Blinded with regard to genotype and treatment group, the pathologist scored 113 midventricle images based on myofiber integrity, intracellular fluid collection, and mitochondrial degeneration. The grading scale ranged from 0 (no injury) to 4 (severe injury) (13) .
Apoptosis. Mice were killed for cardiac apoptosis studies 3, 7, or 10 days after initiation of isoproterenol or saline infusion. Each animal was anesthetized by an intraperitoneal injection of Avertin. Each animal was then killed using cervical dislocation. The heart was immediately exposed using a bilateral clamshell incision. A 20-gauge needle was inserted into the beating right ventricle to serve as a vent. Six milliliters of chilled (4°C) saline was injected into the beating left ventricle via a 20-gauge needle. Immediately after saline injection, 30 mL of chilled (4°C) 4% paraformaldehyde fixative was injected into the left ventricle. Each animal's heart was then removed and stored in 4% paraformaldehyde at 4°C until it was sliced into three sections perpendicular to the long axis of the ventricle. Sections were then stored in 10% neutral buffered formalin for 24 hrs and then embedded in paraffin. Slide sections (5 m) from the midventricular level were stained by in situ terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) using an in situ apoptosis detection kit (TACS 2TdT, Trevigen, Gaithersburg MD) (14) . TUNELpositive nuclei stained blue in this assay. To count the number of TUNEL-positive nuclei, the entire section was scanned at ϫ100 by light microscopy. When TUNEL-positive cells were detected, magnification was changed to ϫ400 to assess whether staining occurred in myocytes. Only TUNEL-positive myocytes were counted in each slide. Any nuclei that were ambiguous were not counted. Round homogeneous dark dots (considered to be artifact) and stained cell debris were carefully eliminated from counting. Brownish nucleilike deposits, considered to be Formalin crystals, were not counted. The number of apoptotic nuclei was normalized to apoptotic nuclei per 10,000 cardiac myocyte nuclei. This was done using the morphometric method. From the positive control of each section, 12 light microscopic fields (400ϫ) were chosen to count the number of myocyte nuclei. Endocardial, midmyocardial, and epicardial areas were chosen from the septum, lateral, ante-rior, and posterior walls of the left ventricle. The number of cardiac myocyte nuclei in each microscope field was counted under a grid covering a total area of 0.0625 mm 2 . Only nuclei that were completely contained within the myocyte contours were counted. The number of nuclei within 12 fields was averaged. The number of TUNEL-positive cells per 10,000 cardiomyocyte nuclei in each slide was calculated as the total number of TUNELpositive cells in each slide divided by the estimated total of myocyte nuclei in each slide multiplied by 10,000.
Statistics. All data were expressed as mean Ϯ SEM. Most of the statistical analyses involved two-way analysis of variance (ANOVA), with predictors for drug treatment and genotype as well as an interaction term. An exception was the comparison of left ventricular contractility (dp/dt max ). In this experiment, isoproterenoltreated ␤2KO mice were compared with isoproterenol-treated wild-type animals, and a Student's t-test was used for the statistical analysis. The saline-treated ␤2KO group was studied simply for comparison with published normal values to validate our experimental technique.
Several of the experiments described were affected by mortality rate among the isoproterenol-treated animals. We investigated whether mortality rate affected the statistical significance of the results by censoring the cohorts where fewer mice died. We repeated the statistical analyses withholding the highest values and then withholding the lowest values from these cohorts. In only one case was the effect of mortality rate significant: liver weight to body weight ratio. When high values were removed, we observed a statistically significant interaction between genotype and treatment (p ϭ .006; two-way analysis of variance).
RESULTS
Mortality. Mortality was defined as death within 17 days of drug infusion onset. On day 17, all animals were killed for analysis. Statistical analysis revealed significantly greater mortality rate among isoproterenol-treated ␤2KO mice compared with isoproterenol-treated wild-type mice (p ϭ .001, chi-squared test using Fisher's exact method). We found that 14 of 36 isoproterenol-treated ␤2KO mice died during two mortality studies, whereas two of 33 isoproterenoltreated wild-type animals died (no salinetreated ␤2KO or wild-type mice died).
Exercise Capacity. To assess whether isoproterenol infusion affected overall cardiovascular function of ␤2KO or wildtype animals, we performed graded exercise treadmill studies. Our data revealed a decrease in exercise capacity after isoproterenol infusion for both wild-type and ␤2KO animals. Although the drug effect was found to be significant, the genotype effect was not significant (Fig. 1) .
Cardiac Function. An increase in lung weight reflects left ventricular dysfunction due to pulmonary congestion as the left ventricle fails. We used lung weight to body weight ratios as an indirect measure of left ventricular cardiac function in ␤2KO and wild-type mice. Analysis of data from this study revealed a significant drug effect (p Ͻ 0.0001, two-way ANOVA) but no genotype effect (p ϭ .7843, twoway ANOVA).
Using Mikro-Tip catheter transducers, we performed direct measurements of left ventricular function in isoproterenoltreated ␤2KO and wild-type animals. We also studied saline-treated ␤2KO mice and compared their left ventricle dp/dt measurements to previously reported values from wild-type mice to validate our experimental technique. The dp/dt values measured in our saline-treated ␤2KO animals were comparable to values previously reported for wild-type mice (15, 16) . Our data did not reveal significant differences in dp/dt max or Ϫdp/dt when isoproterenol-treated ␤2KO and isoproterenol-treated wild-type mice were compared (p ϭ .377 and p ϭ .306, respectively, Student's t-test) (Fig. 2) .
When the right ventricle becomes dysfunctional, central venous pressures increase. An increase in liver weight may reflect right ventricular dysfunction because this organ can become more congested when venous return to the heart is impeded by rising central pressures. An increase in liver weight may also occur for reasons unrelated to cardiac function. We determined liver to body weight ratios and found a significant genotype effect (p ϭ .028, two-way ANOVA; Fig. 3 ). When the data were censored to correct for mortality by removing the highest liver weight values from both cohorts, the interaction between isoproterenol treatment and genotype was significant (p ϭ .006, two-way ANOVA).
Elevated pulmonary artery pressure can lead to right ventricle dysfunction by forcing the right ventricle to eject against a greater resistance. To determine whether the absence of ␤2ARs in the pulmonary vasculature might lead to higher pulmonary artery pressure in ␤2KO mice, we evaluated right ventricle mean systolic pressure. Right ventricular mean systolic pressure reflects the pulmonary artery pressure because the pulmonary valve is open during this phase of the cardiac cycle. Mice without infusion pumps as well as animals that had received saline or isoproterenol infusions were studied. We failed to detect a significant genotype effect on right ventricle mean systolic pressure (p ϭ .488, twoway ANOVA).
Cardiac Structure. We employed three techniques for a study of cardiac structure: heart weight to body weight ratio analysis, assessment of myocyte ultrastructure using electron microscopy, and quantitative measurement of myocyte apoptosis using in situ TUNEL staining. Heart weight to body weight ratio analysis is a simple technique for identi-fying cardiac injury (17) (18) (19) or enlargement (20) . We detected a drug treatment effect but no genotype effect when heart weight to body weight ratio comparisons were made (Fig. 4) .
Electron microscopy can be used to identify subtle structural changes in the heart. Since these changes may occur in the absence of cardiac enlargement, electron microscopy can distinguish differences in heart structure that might not be identified using heart weight to body weight ratio analysis.
We provided a pathologist 113 electron microscopies from midventricular sections of isoproterenol-treated ␤2KO mice, isoproterenol-treated wild-type mice, saline-treated ␤2KO mice, and saline-treated wild-type mice. Blinded to the genotype and treatment group of each sample, we asked the pathologist to evaluate the electron microscopies in terms of myofiber integrity, organelle separation, and mitochondrial integrity. We asked him to provide an overall injury score ranging from 1 to 4 (1 ϭ little or no injury; 4 ϭ severe injury) (13) . He failed to identify a statistically significant genotype effect (p ϭ 0.315, two-way ANOVA; Fig. 5 ).
Myocyte apoptosis is thought to play a role in the progression of cardiac injury after a variety of insults, such as ischemia and drug toxicity (21, 22) . Using in situ TUNEL staining, we found that after 3 and 7 days of isoproterenol infusion, ␤2KO mice demonstrated significantly more apoptosis than wild-type mice (genotype effect: p ϭ .04 and p ϭ .0007, respectively, two-way ANOVA). Salinetreated mice served as control animals. Evaluation of the data from this study also suggested that myocyte apoptosis increased progressively over the course of the study, increasing at 3 days, peaking at 7 days, and then declining again by 10 days (Fig. 6 ). We believe that the decline in myocyte apoptosis at 10 days reflects the elimination of apoptotic cells from the myocardium over time.
In a separate experiment, we compared myocyte apoptosis in animals without infusion pumps to myocyte apoptosis in mice at 7 days of saline and isoproterenol infusion (Fig. 7) . We observed a significant genotype effect (p Ͻ .0001, twoway ANOVA) and saline and isoproterenol treatment effects (p ϭ .03 and p Ͻ .0001, respectively; two-way ANOVA). However, the genotype-treatment interaction terms were not significant (F ϭ 3.87 and F ϭ 1.92, respectively, Bonfer- Figure 1 . Cardiac function in wild-type and ␤2 adrenergic receptor knockout (␤2KO) mice after isoproterenol infusion: graded exercise treadmill testing. Using graded exercise treadmill testing 3 days after completion of a 14-day isoproterenol infusion, we indirectly evaluated cardiac function. The data revealed a decrease in exercise capacity after isoproterenol infusion for both wild-type and ␤2KO animals. Although the drug effect was found to be significant (p Ͻ .0001, two-way analysis of variance), the genotype effect was not significant (p ϭ .248, two-way analysis of variance).
Figure 2.
In vivo assessment of left ventricle contractile function. Mikro-Tip catheter transducers were used to measure left ventricle maximum change in pressure over time (dp/dt max ). We administered intraperitoneal DL-propranolol (30 mg/kg) 30 secs before the onset of data collection to minimize the effects of ␤ adrenergic receptor stimulation. The mean dp/dt max values for isoproterenol-treated wild-type and ␤2 adrenergic receptor knockout (␤2KO) mice were not statistically significant before (not shown) or after propranolol administration (p ϭ .377, Student's t-test).
roni posttests), suggesting that a baseline difference might exist between ␤2KO and wild-type mice in terms of myocyte apoptosis.
Electrophysiology. We evaluated five isoproterenol-treated ␤2KO mice and five saline-treated ␤2KO animals using ECG. No evidence of myocardial injury was detected in isoproterenol-treated ␤2KO an-imals by ECG. No abnormalities in terms of rate, rhythm, intervals, or axis were observed either at baseline or after isoproterenol or saline infusions (23) .
Effects of Isoproterenol Infusion on Blood Pressure and Heart Rate. Afterload reduction is an indirect means by which peripheral ␤2AR activation might afford protection to the hearts of wild-type animals relative to ␤2KO mice. Activation of ␤2ARs in the peripheral vasculature has been shown to mediate vasodilation (24, 25) . Using a noninvasive blood pressure measurement device, we performed a series of experiments to determine whether differences in blood pressure existed between ␤2KO and wildtype mice. We found no significant differences in systolic blood pressure between isoproterenol-treated ␤2KO and wildtype mice (p ϭ .09, Bonferroni/Dunn post hoc analysis, repeated-measures ANOVA; Fig. 8 ).
Tachycardia-induced cardiac injury has been well documented (26, 27) . To determine whether heart rate differences existed between isoproterenol-treated ␤2KO and wild-type mice, we compared heart rates in the mice during the infusions. Results of this experiment suggested no significant differences between the heart rates of isoproterenol-treated ␤2KO and isoproterenol-treated wildtype animals (p ϭ .99, Bonferroni/Dunn post hoc analysis, repeated-measures ANOVA).
DISCUSSION
Our results provide evidence that ␤2ARs mitigate some of the deleterious effects of chronic ␤1AR stimulation. In mice subjected to a chronic infusion of the nonselective ␤AR agonist isoproterenol, we observed higher mortality rate in ␤2KO mice than in wild-type animals. Moreover, we observed more apoptosis in the hearts of ␤2KO mice.
The results of our study indicate that ␤2KO and wild-type mice are more dissimilar than we initially believed. Previous investigations suggested that ␤2KO animals were normal in size and demonstrated heart rates and blood pressures similar to wild-type control animals. Only during significant stress were differences between ␤2KO and wild-type mice apparent. ␤2KO mice were found to become hypertensive in response to exercise. However, they also demonstrated enhanced exercise capacity and more efficient oxygen utilization during exercise (lower respiratory exchange ratio at a given workload) (12) . Our data suggest that even modest stress (such as saline infusion) can elicit differences in myocyte apoptosis between ␤2KO and wild-type mice, indicating that the absence of ␤2AR signaling is important even when physiologic differences are not apparent. . Liver weight to body weight ratio analysis after isoproterenol infusion. Analysis of data from this experiment revealed a significant genotype effect on liver weight to body weight ratio (p ϭ .028, two-way analysis of variance). When data were corrected for mortality by removing the highest liver weights from each group, the interaction between isoproterenol treatment and genotype was found to be significant (p ϭ .006, two-way analysis of variance). ␤2KO, ␤2 adrenergic receptor knockout mice. A growing body of evidence suggests that ␤2AR stimulation is protective (6, 9, 28) . However, the mechanisms by which ␤2AR-mediated protection is conferred remain unclear. ␤2AR-mediated reduction in myocyte apoptosis by a G idependent signaling pathway is likely one factor. The capacity of ␤2ARs but not ␤1ARs to couple to G i represents an important point of divergence between ␤1AR and ␤2AR signaling, and other G idependent signaling pathways may also contribute to the protective effect of ␤2AR stimulation.
Evidence now suggests that in cardiac myocytes, receptor targeting and trafficking mediated by interactions with cellular scaffolding proteins dictate subtypespecific signaling. The PDZ domain binding motifs at the carboxyl termini of ␤ARs differ significantly between ␤1ARs and ␤2ARs and mediate interactions with different cellular scaffolding proteins (29 -32) . For instance, the ␤1AR PDZ motif interacts with postsynaptic density protein-95 and related proteins. This interaction prevents agonist-induced internalization (33) and appears to prevent ␤1AR coupling to G i . Disruption of this motif leads to efficient ␤1AR-Gi coupling Figure 5 . Assessment of myocyte ultrastructure after isoproterenol infusion using electron microscopy. A trained specialist (cardiac pathologist) assessed the ultrastructure injury score to be 2.9 Ϯ 0.2 in isoproterenol-treated ␤2 adrenergic receptor knockout mice (␤2KO), 2.0 Ϯ 0.2 in isoproterenol-treated wild-type mice, 1.6 Ϯ 0.2 in saline-treated ␤2KO mice, and 2.0 Ϯ 0.1 in saline-treated wild-type mice. Although a statistically significant treatment effect was identified (p ϭ .001, two-way analysis of variance), a genotype effect was not observed (p ϭ .315, two-way analysis of variance).
Figure 6.
Quantitative determination of myocyte apoptosis using in situ terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) staining. Quantitative determination of myocyte apoptosis was performed at three time points: 3, 7, and 10 days after isoproterenol pump insertion. *A significant genotype effect was observed at 3-and 7-day time points (p ϭ .04 and p ϭ .0007, respectively). Saline-treated mice served as control animals (data not shown). ␤2KO, ␤2 adrenergic receptor knockout mice.
in neonatal cardiac myocytes (29) . In contrast, the ␤2AR PDZ motif interacts with different PDZ domain-containing proteins, such as ezrin-binding-50/ sodium-hydrogen exchange regulatory factor family proteins, which are responsible for receptor sorting between recycling and degradative endocytic pathways (32) . In vitro studies demonstrate that mutation of the ␤2AR PDZ motif disrupts ␤2AR-G i coupling possibly by interfering with receptor recycling after endocytosis (30) .
Our data suggest that ␤2AR activation reduces myocyte apoptosis in vivo.
Whether myocyte apoptosis contributed directly to the higher mortality rate among isoproterenol-treated ␤2KO animals is unclear. We did not observe greater impairment of cardiac function in isoproterenol-treated ␤2KO mice relative to isoproterenol-treated wild-type mice. However, structural injury leading to events such as lethal arrhythmias remains a possible cause of the higher mortality. ␤2KO mice may be more susceptible to arrhythmias due to altered signaling in their myocytes. Other investigators have reported that in a canine model, arrhythmogenicity increases dur-ing ␤1AR (but not ␤2AR) activation by virtue of a cyclic adenosine monophosphate-dependent pathway (34) . Other investigators have also reported that ␤2AR activation attenuates ␤1AR-mediated arrhythmias (35) . We did not observe arrhythmias during our ECG analyses. However, this approach cannot be considered an adequate assessment method.
Noncardiac events may also have played a role in the higher mortality rate among our isoproterenol-treated ␤2KO mice. For example, changes in the hepatic, renal, and/or central nervous systems may have adversely affected the ␤2KO mice. In addition, isoproterenol infusion may have affected metabolic and neuroendocrine pathways differently in ␤2KO mice compared with wild-type animals.
Our data also revealed a significant genotype effect on liver weight to body weight ratios. However, we have not determined why this phenomenon occurred. One possibility is that the livers of ␤2KO mice are more susceptible to direct effects of isoproterenol infusion. Another possibility is that venous congestion occurs in the livers of ␤2KO mice due to impaired right heart function, although we did not obtain direct evidence of right ventricular dysfunction.
In summary, the results of this study suggest that in vivo ␤2AR activation is antiapoptotic and contributes to myocardial protection. . Myocyte apoptosis after 7 days of saline or isoproterenol infusion. We detected a genotype effect (#) (p Ͻ .0001, two-way analysis of variance) as well as saline and isoproterenol treatment effects (, *) (p ϭ .03 and p Ͻ .0001, respectively, two-way analysis of variance) in terms of myocyte apoptosis when ␤2 adrenergic receptor knockout (␤2KO) and wild-type mice were compared at 7 days of infusion. However, further analysis suggested that the genotype-treatment interaction terms were not significant (F ϭ 3.87 and F ϭ 1.92, respectively, Bonferroni posttests). The numbers of animals in each study group were eight isoproterenol-treated ␤2KO mice, five isoproterenol-treated wild-type mice, eight saline-treated ␤2KO mice, eight saline-treated wild-type mice, five ␤2KO mice without infusion pumps, and nine wild-type mice without infusion pumps. TUNEL, terminal deoxynucleotide transferase-mediated dUTP nick-end labeling. Figure 8 . Noninvasive blood pressure measurements during isoproterenol infusion: wild-type vs. ␤2 adrenergic receptor knockout (␤2KO) mice. No significant difference in systolic blood pressure was detected when isoproterenol-treated ␤2KO mice were compared with isoproterenol-treated wild-type animals (p ϭ .09; Bonferroni/Dunn post hoc analysis, repeated-measures analysis of variance).
T he results of this study suggest that in vivo ␤2 adrenergic receptor activation is antiapoptotic and contributes to myocardial protection.
